GlassScriptPhysician profile
Charles H Chesnut
NPI 1972823532
$76,230.46
in general payments reported to CMS, 2019-2025
32 companies · $12K in 2025
The $12K reported for 2025 was more than what 96% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.25 · 2020: $13.73 · 2021: $211 · 2022: $16K · 2023: $5,839 · 2024: $42K · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $48K · Travel and Lodging: $4,398 · Education: $4,000 · Food and Beverage: $2,815 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $48,300.00 |
| Travel and Lodging | $4,398.10 |
| Education | $4,000.00 |
| Food and Beverage | $2,814.96 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $52,027.36 | 2023-2025 | Arthrex |
| Innocoll Pharmaceuticals Limited | $15,628.95 | 2022 | |
| Intuitive Surgical, INC. | $5,410.77 | 2023-2024 | Da Vinci Surgical System |
| Tela Bio, INC. | $1,039.56 | 2021-2025 | Ovitex 2s, Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Ethicon INC. | $630.00 | 2024 | |
| Goode Surgical INC | $255.04 | 2023-2025 | |
| Ethicon US, LLC | $218.39 | 2022-2023 | Echelon Flex |
| Abbvie INC. | $150.88 | 2023-2025 | Strattice Reconstructive Tissue Matrix Bps |
| Smith+Nephew, INC. | $144.85 | 2022-2023 | Oasis |
| Avita Medical Americas, LLC | $138.89 | 2024 | |
| Acera Surgical, INC. | $59.45 | 2021-2024 | Restrata Wound Matrix |
| Boston Scientific Corporation | $41.49 | 2022-2024 | Spyglass Discover |
| Allergan, INC. | $39.45 | 2021-2022 | |
| Abiomed | $36.28 | 2025 | |
| Davol INC. | $33.01 | 2023-2025 | Phasix Mesh |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $31.14 | 2024 | Dovato |
| Olympus America INC. | $30.73 | 2023 | |
| Kci USA, INC. | $28.56 | 2020-2023 | Prevena |
| Cvrx, INC. | $28.08 | 2025 | Barostim Neo System |
| Amgen INC. | $26.59 | 2024 | Otezla, Repatha |
| Polynovo North America LLC | $25.25 | 2024 | Novosorb Btm |
| Innovation Technologies INC | $21.59 | 2024 | Irrisept |
| Novo Nordisk INC | $21.54 | 2023 | Rybelsus, Ozempic |
| Medtronic, INC. | $21.22 | 2024 | Signia |
| Heron Therapeutics, INC. | $19.69 | 2025 | Zynrelef |
| Vertex Pharmaceuticals Incorporated | $19.57 | 2025 | |
| Dilon Technologies, INC. | $19.12 | 2024 | Hemoblast Bellows |
| 180 Medical, INC. | $19.04 | 2021 | |
| Merck Sharp & Dohme LLC | $17.25 | 2019 | |
| Antares Pharma, INC. | $16.86 | 2024 | Xyosted |
| Integra Lifesciences Corporation | $15.11 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Astrazeneca Pharmaceuticals LP | $14.75 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Chesnut listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.